您好，欢迎来到易推广！ 请登录 免费注册

上海陶术生物科技有限公司 主营产品：生物试剂,实验服务等

当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示

企业档案

会员类型：会员

已获得易推广信誉   等级评定
139成长值

(0 -40)基础信誉积累，可浏览访问

(41-90)良好信誉积累，可接洽商谈

(91+  )优质信誉积累，可持续信赖

易推广会员：5年

工商认证 【已认证】

最后认证时间：

注册号： 【已认证】

法人代表： 【已认证】

企业类型：生产商 【已认证】

注册资金：人民币万 【已认证】

产品数：86101

参观次数：3228181

手机网站：http://m.yituig.com/c135739/

旗舰版地址：http://tsbiochem.app17.com

自主品牌

自主品牌

已选条件

  • T76722Sarilumab；萨瑞鲁单抗REGN-88|||SAR-153191；REGN-88|||SAR-153191

    Sarilumab （SAR-153191）is a potent interleukin-6 IL-6 receptor antagonist and a human immunoglobulin G1 monoclonal antibody. Sarilumab inhibits IL-6-mediated signaling and reduces inflammation.Sarilumab is used for the prevention and treatment of rheumatoid arthritis.

    价 格：￥电议型 号：T76722产 地：中国大陆

  • T76721Zalutumumab；化合物 ZalutumumabZalutumumab

    Zalutumumab, a fully human IgG1 monoclonal antibody, exhibits high affinity for the epidermal growth factor receptor (EGFR), selectively targeting its domain III. It functions by inhibiting the binding of the epidermal growth factor (EGF) and obstructing the receptor´s active conformation through steric hindrance. With EC50 values of 7 nM for its IgG and 19 nM for the Fab fragment, Zalutumumab demonstrates potent interaction capabilities. This compound is primarily utilized in cancer resea

    价 格：￥电议型 号：T76721产 地：中国大陆

  • T76720Farletuzumab；法妥组单抗MORAb-003；MORAb-003

    Farletuzumab (MORAb-003) is a potent inhibitor of folate receptor-α (FRα). Farletuzumab is a humanized monoclonal antibody with a high affinity for FRα. Farletuzumab inhibits the growth of cells that overexpress FRα. Farletuzumab can be used to study cancer.

    价 格：￥电议型 号：T76720产 地：中国大陆

  • T76718Brentuximab；布妥昔单抗Brentuximab

    Brentuximab is a chimeric antibody targeting CD30 and is a naked antibody to Brentuximab vedotin.Brentuximab has antitumor activity and may be used to study relapsed or refractory Hodgkin´s lymphoma.

    价 格：￥电议型 号：T76718产 地：中国大陆

  • T76717Serplulimab；斯鲁利单抗HLX 10；HLX 10

    Serplulimab (HLX 10) is a humanized monoclonal anti-antibody to PD-1. Serplulimab has antitumor activity and can be used in small cell lung cancer and esophageal squamous cell carcinoma.

    价 格：￥电议型 号：T76717产 地：中国大陆

  • T76716Cadonilimab；化合物 CadonilimabCadonilimab

    Cadonilimab (AK104) is a humanized antibody engineered from the IgG1 scaffold and targets PD1/CTLA4. It is utilized in the research of metastatic cervical cancer [1] [2].

    价 格：￥电议型 号：T76716产 地：中国大陆

  • T76715Envafolimab；化合物 EnvafolimabEnvafolimab

    Envafolimab (ASC 22; KN 035), a recombinant humanized single-domain anti-PD-L1 antibody, integrates the anti-PD-L1 domain with the Fc fragment of the human IgG1 antibody. It inhibits the PD-L1 and PD-1 interaction with an IC 50 of 5.25?nM, indicating its research potential for solid tumors [1] [2] [3].

    价 格：￥电议型 号：T76715产 地：中国大陆

  • T76714Sugemalimab；化合物 SugemalimabSugemalimab

    Sugemalimab, a fully human, full-length, IgG4 monoclonal antibody (mAb) targeting programmed death ligand 1 (PD-L1), exhibits anticancer activities and is applicable in non-small cell lung cancer research [1].

    价 格：￥电议型 号：T76714产 地：中国大陆

  • T76713Inebilizumab；伊奈利珠单抗MEDI 551|||MT-0551|||16C4-aFuc|||VIB-0551；MEDI 551|||MT-0551|||16C4-aFuc|||VIB-05

    Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used to treat a range of autoimmune diseases associated with CD19 B cells, such as multiple sclerosis and optic neuromyelitis.

    价 格：￥电议型 号：T76713产 地：中国大陆

  • T76712Satralizumab；化合物 SatralizumabSatralizumab

    Satralizumab, a humanized monoclonal antibody and potent Interleukin-6 (IL-6) inhibitor, prevents the formation and progression of descending thoracic aorta aneurysm (dTAA) in Rattus norvegicus. It is also used in research for neuromyelitis optica spectrum disorder (NMOSD) and dTAA [1] [2].

    价 格：￥电议型 号：T76712产 地：中国大陆

  • T76711Golimumab；戈利木单抗MK-8259|||SCH 900259|||CNTO-148；MK-8259|||SCH 900259|||CNTO-148

    Golimumab (CNTO-148) is a potent humanized anti-TNFα IgG1κ monoclonal antibody.Golimumab has anti-inflammatory and anticancer activity, inhibits the production of IL-6 and IL-1β, and induces apoptosis.Golimumab can be used to prevent inflammation and destruction of cartilage or bone, and can be used to study rheumatoid arthritis and cancer. Golimumab can be used to prevent inflammation and cartilage or bone destruction and can be used to study rheumatoid arthritis and cancer.

    价 格：￥电议型 号：T76711产 地：中国大陆

  • T76710Lanadelumab；化合物 LanadelumabLanadelumab

    Lanadelumab (SHP643), a humanized IgG1 monoclonal antibody, targets plasma kallikrein (pKal) with a K i value of 0.12 nM, effectively inhibiting both its free form and its interaction with high molecular weight kininogen (HMWK)-bound pKal. This compound shows promise for hereditary angioedema research [1] [2].

    价 格：￥电议型 号：T76710产 地：中国大陆

  • T76709Zimberelimab；化合物 ZimberelimabZimberelimab

    Zimberelimab, a fully human IgG4 monoclonal antibody targeting PD-1 with high affinity and selectivity, exhibits antitumor activities. It is applicable in research on various cancers, including cervical cancer, non-small cell lung cancer, and classical Hodgkin’s lymphoma [1].

    价 格：￥电议型 号：T76709产 地：中国大陆

  • T76708Penpulimab；化合物 PenpulimabPenpulimab

    Penpulimab, an anti-PD-1 monoclonal antibody featuring an IgG1 backbone, possesses antitumor activities [1].

    价 格：￥电议型 号：T76708产 地：中国大陆

  • T76707Brentuximab vedotin；维布妥昔单抗SGN-35；SGN-35

    Brentuximab vedotin (SGN-35) is an antibody-activated molecule coupling (ADC) targeting CD30 with antitumor activity for the study of lymphomas.

    价 格：￥电议型 号：T76707产 地：中国大陆

  • T76706Varlilumab；伐立鲁单抗CDX-1127；CDX-1127

    Varlilumab (CDX-1127) is a novel human IgG1 anti-CD27 monoclonal antibody. Varlilumab has antitumor activity and can be used to study advanced solid tumors.

    价 格：￥电议型 号：T76706产 地：中国大陆

  • T76705Utomilumab乌托鲁单抗PF 05082566|||PF-2566

    Utomilumab (PF 05082566) is a humanized IgG2 antibody targeting the T-cell co-stimulatory receptor 4-1BB/CD137 and a 4-1BB/CD137 agonist.Utomilumab has antitumor activity and may be used in the study of patients with advanced malignancies.

    价 格：￥电议型 号：T76705产 地：中国大陆

  • T76704Tralokinumab；曲罗芦单抗CAT-354|||LP 0162；CAT-354|||LP 0162

    Tralokinumab is a fully human IgG4 monoclonal antibody with a high affinity for IL-13 alone. Tralokinumab´s potential anti-inflammatory activity prevents IL-13 receptor interaction and subsequent downstream signaling and can be used to study atopic dermatitis (AD).

    价 格：￥电议型 号：T76704产 地：中国大陆

  • T76703Tislelizumab化合物 Tislelizumab替雷利珠

    Tislelizumab is a monoclonal antibody that exhibits strong binding affinity for the PD-1 receptor and reduces Fcγ receptor engagement on macrophages, preventing antibody-dependent phagocytosis, a pathway for T cell elimination and possible resistance to anti-PD-1 treatment. It is applicable in investigating advanced squamous non-small-cell lung cancer [1].

    价 格：￥电议型 号：T76703产 地：中国大陆

  • T76702Sutimlimab；苏替莫单抗Sutimlimab

    Sutimlimab is a novel monoclonal antibody targeting complement protein C1. Sutimlimab is commonly used as a C1 inhibitor to treat cold agglutina-associated hemolysis.

    价 格：￥电议型 号：T76702产 地：中国大陆

132333435363738394041下一页共41页

展台首页| 公司简介| 供应产品| 产品目录| 公司动态| 荣誉证书| 招聘信息| 技术中心| 联系我们| 会员管理

易推广  设计制作，未经允许翻录必究.Copyright(C) 2009 http://www.yituig.com, All rights reserved.

以上信息由企业自行提供，信息内容的真实性、准确性和合法性由相关企业负责，易推广对此不承担任何责任.   总访问量：3228181

中国彩虹热线

快速导航

返回顶部
在线咨询

提交